Compare GTE & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GTE | CDXS |
|---|---|---|
| Founded | 2003 | 2002 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Major Chemicals |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 256.3M |
| IPO Year | 2007 | 2008 |
| Metric | GTE | CDXS |
|---|---|---|
| Price | $6.18 | $2.29 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 295.6K | ★ 784.1K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.82 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $374,460,000.00 | $138,590,000.00 |
| Revenue This Year | $1.39 | $7.73 |
| Revenue Next Year | $2.84 | $14.24 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 41.99 | 32.30 |
| 52 Week Low | $3.09 | $0.96 |
| 52 Week High | $9.74 | $3.87 |
| Indicator | GTE | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 26.76 | 40.20 |
| Support Level | $5.16 | $1.57 |
| Resistance Level | $6.63 | $2.71 |
| Average True Range (ATR) | 0.42 | 0.17 |
| MACD | -0.12 | -0.03 |
| Stochastic Oscillator | 1.40 | 1.44 |
Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. The majority of its revenue comes from operations in Colombia.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.